211 related articles for article (PubMed ID: 17095023)
1. Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells.
Selkirk JV; Nottebaum LM; Lee J; Yang W; Foster AC; Lechner SM
Neuropharmacology; 2007 Feb; 52(2):459-66. PubMed ID: 17095023
[TBL] [Abstract][Full Text] [Related]
2. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway.
Caruso C; Carniglia L; Durand D; Gonzalez PV; Scimonelli TN; Lasaga M
Mol Cell Endocrinol; 2012 Jan; 348(1):47-54. PubMed ID: 21803120
[TBL] [Abstract][Full Text] [Related]
3. Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational states.
Nickolls SA; Fleck B; Hoare SR; Maki RA
J Pharmacol Exp Ther; 2005 Jun; 313(3):1281-8. PubMed ID: 15743921
[TBL] [Abstract][Full Text] [Related]
4. Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.
Xiang Z; Pogozheva ID; Sorenson NB; Wilczynski AM; Holder JR; Litherland SA; Millard WJ; Mosberg HI; Haskell-Luevano C
Biochemistry; 2007 Jul; 46(28):8273-87. PubMed ID: 17590021
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin receptor 4 is induced in nerve-injured motor and sensory neurons of mouse.
Tanabe K; Gamo K; Aoki S; Wada K; Kiyama H
J Neurochem; 2007 May; 101(4):1145-52. PubMed ID: 17286587
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin 4 receptors interact with antimicrobial frog peptide analogues.
Do EU; Jo EB; Choi G; Piao LZ; Shin J; Seo MD; Kang SJ; Lee BJ; Kim KH; Kim JB; Kim SI
Biochem Biophys Res Commun; 2006 May; 343(4):1094-100. PubMed ID: 16579969
[TBL] [Abstract][Full Text] [Related]
7. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
[TBL] [Abstract][Full Text] [Related]
8. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
9. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological analyses of two naturally occurring porcine melanocortin-4 receptor mutations in domestic pigs.
Fan ZC; Sartin JL; Tao YX
Domest Anim Endocrinol; 2008 May; 34(4):383-90. PubMed ID: 18262384
[TBL] [Abstract][Full Text] [Related]
11. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
12. Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.
Muceniece R; Zvejniece L; Vilskersts R; Liepinsh E; Baumane L; Kalvinsh I; Wikberg JE; Dambrova M
Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):416-20. PubMed ID: 18028105
[TBL] [Abstract][Full Text] [Related]
13. 4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.
Chen C; Pontillo J; Fleck BA; Gao Y; Wen J; Tran JA; Tucci FC; Marinkovic D; Foster AC; Saunders J
J Med Chem; 2004 Dec; 47(27):6821-30. PubMed ID: 15615531
[TBL] [Abstract][Full Text] [Related]
14. Agonist-dependent internalization of the human melanocortin-4 receptors in human embryonic kidney 293 cells.
Gao Z; Lei D; Welch J; Le K; Lin J; Leng S; Duhl D
J Pharmacol Exp Ther; 2003 Dec; 307(3):870-7. PubMed ID: 14534363
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and functional characterisation of the human melanocortin 4 receptor in Sf9 cells.
Dolby V; Collén A; Lundqvist A; Cronet P
Protein Expr Purif; 2004 Oct; 37(2):455-61. PubMed ID: 15358370
[TBL] [Abstract][Full Text] [Related]
16. A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation.
Selkirk JV; Nottebaum LM; Ford IC; Santos M; Malany S; Foster AC; Lechner SM
J Biomol Screen; 2006 Jun; 11(4):351-8. PubMed ID: 16751331
[TBL] [Abstract][Full Text] [Related]
17. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of the potent cyclic and linear melanocortin analogues.
Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
[TBL] [Abstract][Full Text] [Related]
19. A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.
Rettenbacher E; Tarnow P; Brumm H; Prayer D; Wermter AK; Hebebrand J; Biebermann H; Hinney A; Widhalm K
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):7-12. PubMed ID: 17286227
[TBL] [Abstract][Full Text] [Related]
20. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones.
Ni XP; Butler AA; Cone RD; Humphreys MH
J Hypertens; 2006 Nov; 24(11):2239-46. PubMed ID: 17053546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
